flibanserin (trade name girosa) was an investigational compound studied as an oral daily treatment to improve sexual desire in pre-menopausal women suffering from decreased sexual desirea medical condition known as hypoactive sexual desire disorder (hsdd) icd-10 f52.0. marketing was terminated in October 2010 following a negative report from the fda.


prelaunch unbranded advertorial campaign

hsdd awareness unbranded campaign

measures branded campaign

rated d branded campaign

world of desire branded campaign

Print | Sitemap
© Rob Quandt